Atlas Trials

Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam

Clinical trial NCT00736931 · COMPLETED

Trial details

NCT number
NCT00736931
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2008-07-01
Primary completion
2008-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.